Search
Menu
Sheetak -  Cooling at your Fingertip 11/24 LB

Optical Spectroscopy Applied to PAT for In-Line Monitoring in Pharmaceutical Manufacturing

Apr 13, 2022
Facebook X LinkedIn Email
TO VIEW THIS WEBINAR:
Login  Register
Sponsored by
Metrohm USA Inc.
About This Webinar
Martin Warman and Paul Gillham address the need for and processes involved in improving in-line monitoring software for pharmaceutical manufacturing.

***This presentation premiered during the 2022 Photonics Spectra Spectroscopy Conference. For more information on Photonics Media conferences, visit events.photonics.com.  

About the presenters:
Martin WarmanMartin Warman is director of Martin Warman Consultancy Ltd. He has recently stepped down as a professor of practice at the University of Strathclyde, and from being the research director for the Medicine Manufacturing Innovation Centre (MMIC) but continues to work with the MMIC in a consultancy role. He worked previously for seven years at Vertex Pharmaceuticals, developing the Vertex continuous manufacturing (CM) platform, on which the first approved CM products are manufactured. He has over 25 years of experience in the field of process development, having previously led the Global Process Analytical Technology (PAT) Development Team at Pfizer Global Manufacturing. He plays an active role in ASTM E55 as the technical lead on standards for PAT sampling, PAT-enabled control systems, and CM. Warman is also an associate member of Centre for Process Analytics and Control Technology (CPACT).

Paul GillhamPaul Gillham is director of innovation at Optimal Industrial Technologies Ltd. in the UK. He has more than a decade of experience in PAT, software, and compliance—especially for quality-by-design (QbD) innovation in pharmaceutical manufacturing.
spectroscopySoftwarepharmaceuticalprocess analytical technology
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.